1. Home
  2. RNW vs NAMS Comparison

RNW vs NAMS Comparison

Compare RNW & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNW
  • NAMS
  • Stock Information
  • Founded
  • RNW 2011
  • NAMS 2019
  • Country
  • RNW United Kingdom
  • NAMS Netherlands
  • Employees
  • RNW N/A
  • NAMS N/A
  • Industry
  • RNW Electric Utilities: Central
  • NAMS Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNW Utilities
  • NAMS Health Care
  • Exchange
  • RNW Nasdaq
  • NAMS Nasdaq
  • Market Cap
  • RNW 2.4B
  • NAMS 2.5B
  • IPO Year
  • RNW N/A
  • NAMS N/A
  • Fundamental
  • Price
  • RNW $6.56
  • NAMS $17.96
  • Analyst Decision
  • RNW Strong Buy
  • NAMS Strong Buy
  • Analyst Count
  • RNW 1
  • NAMS 8
  • Target Price
  • RNW $7.50
  • NAMS $42.88
  • AVG Volume (30 Days)
  • RNW 831.9K
  • NAMS 893.6K
  • Earning Date
  • RNW 06-16-2025
  • NAMS 08-06-2025
  • Dividend Yield
  • RNW N/A
  • NAMS N/A
  • EPS Growth
  • RNW 16.07
  • NAMS N/A
  • EPS
  • RNW 0.13
  • NAMS N/A
  • Revenue
  • RNW $1,135,947,896.00
  • NAMS $47,140,000.00
  • Revenue This Year
  • RNW N/A
  • NAMS N/A
  • Revenue Next Year
  • RNW $40.34
  • NAMS N/A
  • P/E Ratio
  • RNW $51.85
  • NAMS N/A
  • Revenue Growth
  • RNW 19.36
  • NAMS 586.97
  • 52 Week Low
  • RNW $5.15
  • NAMS $14.06
  • 52 Week High
  • RNW $7.49
  • NAMS $27.29
  • Technical
  • Relative Strength Index (RSI)
  • RNW 47.68
  • NAMS 42.30
  • Support Level
  • RNW $6.66
  • NAMS $20.06
  • Resistance Level
  • RNW $7.17
  • NAMS $21.91
  • Average True Range (ATR)
  • RNW 0.19
  • NAMS 1.41
  • MACD
  • RNW -0.04
  • NAMS -0.20
  • Stochastic Oscillator
  • RNW 9.62
  • NAMS 4.45

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

Share on Social Networks: